Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday share tips: Eco Animal Health, Intertek

(Sharecast News) - The Financial Mail on Sunday's Midas column tipped shares of Eco Animal Health to its readers, touting the company's animal drug pipeline.

Long-term prospects for the firm were robust, Midas said, with sales seen rising to nearly £93m in the current year and to over £100m in 2026.

Profits were growing alongside and the rate of growth should increase as new drugs hit the market.

Eco's main product was the antibiotic Aivlosin, which had the benefit of only being used for short periods and with minimal dosage when animals were truly sick.

But the company had several other drugs that were set to come to market, including two vaccines in 2025.

Together those vaccines should generate annual sales of around £30m and several more were set to start being marketed before 2030.

"Eco Animal Health has been through tough times but long-term prospects are robust, as CEO David Hallas has ambitious plans for growth and is on track to deliver them. At £1.23, the shares are a buy."

The Sunday Times's Lucy Tobin recommended shares of Intertek.

In her opinion, the shares were set to get a boost from the company's increase in its targeted dividend payout ration to roughly 65% of earnings starting from 2024.

Furthermore, the global thirst for compliance and testing was only going to increase.

At 21 estimated earnings Intertek's shares were "not at all cheap", she conceded, although that multiple was about a tenth below its historical average.

Indeed, analysts at UBS expected the shares to recover the 5,900p mark in 12 months' time.

Like-for-like sales meanwhile had grown by 6% over the year ending in March, its best showing in a decade.

"And as global demand for product regulation, testing and accreditation keeps accelerating - the trend is, basically, for more health and safety - Intertek looks increasingly appealing."

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Solar panels, OBR, Chevron
(Sharecast News) - California's home-insurance safety net does not have enough money to pay all of the claims from damage caused by the Los Angeles wildfires and has asked private insurers to contribute $1bn toward those claims. All private insurers operating in California are required to contribute to the Fair plan, a plan of last resort established so all Californians would have access to fire insurance. More than 450,000 California homeowners got their insurance through the Fair plan in 2024 - more than double the number in 2020. As of 4 February, the plan had received more than 4,700 claims from the Palisades and Eaton fires, almost half of which were for "total losses". - Guardian
Wednesday newspaper round-up: British economy, Heathrow, FOS
(Sharecast News) - The British economy is on course to expand by 1.5% this year after the budget gave a boost to public spending but could be blown off course if Donald Trump goes ahead with threatened tariffs, a leading economic thinktank has warned. In a boost to Rachel Reeves after a bruising month of negative economic figures, the National Institute of Economic and Social Research (NIESR) upped its annual growth prediction from 1.2% to 1.5%. - Guardian
Tuesday newspaper round-up: OpenAI, EVs, gas prices
(Sharecast News) - Elon Musk escalated his feud with OpenAI and its CEO Sam Altman on Monday. The billionaire is leading a consortium of investors that announced it had submitted a bid of $97.4bn for "all assets" of the artificial intelligence company to OpenAI's board of directors. The startup, which operates ChatGPT, has been working to restructure itself away from its original non-profit status. OpenAI also operates a for-profit subsidiary, and Musk's unsolicited offer could complicate the company's plans. The Wall Street Journal first reported the proposed bid. - Guardian
Monday newspaper round-up: Service charge, BP, Heathrow, Elon Musk
(Sharecast News) - An increasingly complex tax system is burdening the government and businesses with hundreds of millions of pounds more in administration costs, Whitehall's spending watchdog has warned. The report by the National Audit Office (NAO) also said "poor levels of service" meant some taxpayers and their representatives were "finding it more difficult to deal with their tax matters and are losing trust in HM Revenue & Customs [HMRC]". - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.